Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • twoshoes@lemmy.world
    link
    fedilink
    English
    arrow-up
    3
    arrow-down
    2
    ·
    1 year ago

    The problem is, that the law is not absolute. Neither in it’s writing nor it’s application.

    Large companies regularly break the law (especially data protection) and face very little consequences. Either because they can afford a staff of lawyers to find and build loopholes, or through schmoozing with the right desicion makers. Paying a fine of 20 million is not much when you made 20 billion (20 thousand million) in profit.

    Even more so, very large companies (think Facebook or Google) hold enough political power to influence or even change laws.